Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Mar 2026 for Protagonist Therapeutics, Inc, €267k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Harold e. Selick: trading record in brief
All filings by Harold e. Selick on record concern Protagonist Therapeutics, Inc. Over a trading history stretching from 10 April 2023 to 26 March 2026, the count stands at 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 27 March 2026, reports an option exercise of €267k in Protagonist Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harold e. Selick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
24,000 shares@ US$12.8877.2% of flowCommon StockSEC:0001104659-26-036318:0
14,299 shares@ US$4.2114.9% of flowCommon StockSEC:0001104659-26-003386:0
2,695 shares0Common StockSEC:0001104659-26-001479:0
10,725 shares@ US$1.163.2% of flowCommon StockSEC:0001104659-25-042608:0
5,130 shares0Common StockSEC:0001104659-25-001430:0
6,490 shares@ US$1.893.3% of flowCommon StockSEC:0001104659-24-033132:0
6,196 shares@ US$0.871.4% of flowCommon StockSEC:0001104659-23-044168:0
7 of 7 declarations
